2-aminoadipic acid has been researched along with methotrexate in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (53.85) | 18.2507 |
2000's | 6 (46.15) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mihara, M; Moriya, Y; Takagi, N; Takeda, Y; Urakawa, K | 3 |
Kaneko, E; Mihara, M; Suzuki, T; Takagi, N; Takeda, Y | 1 |
Hiraoka, M; Mihara, M; Miyasaka, N; Takeda, Y | 1 |
Han, YH; Kato, Y; Sugiyama, Y | 2 |
Akamatsu, K; Kamatani, N; Kawamura, A; Mihara, M; Suzuki, T; Takeda, Y; Urakawa, K | 1 |
Asoh, Y; Han, YH; Kato, Y; Sugiyama, Y; Terao, K; Watanabe, Y | 1 |
Akamatsu, K; Kawamura, A; Mihara, M; Takagi, N; Takeda, Y; Urakawa, K | 1 |
Chen, JF; Cronstein, BN; Delano, D; Desai, A; Fink, JS; Jacobson, MA; Montesinos, MC | 1 |
Akabane, H; Komai, M; Masuda, T; Nagai, H; Nagao, K; Tanaka, H | 1 |
Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Minamino, T; Mori, H; Node, K; Ogai, A; Ogita, H; Sanada, S; Shinozaki, Y; Takashima, S; Tomoike, H | 1 |
1 trial(s) available for 2-aminoadipic acid and methotrexate
Article | Year |
---|---|
A novel antifolate, MX-68, inhibits the development of autoimmune disease in MRL/lpr mice.
Topics: 2-Aminoadipic Acid; Administration, Oral; Animals; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Blood Urea Nitrogen; Cell Division; Cholesterol; DNA, Single-Stranded; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Kidney Diseases; Lupus Nephritis; Lymph Nodes; Methotrexate; Mice; Mice, Inbred MRL lpr; Picrates; Proteinuria; Specific Pathogen-Free Organisms; Spleen | 1997 |
12 other study(ies) available for 2-aminoadipic acid and methotrexate
Article | Year |
---|---|
In vitro and in vivo biological activities of a novel nonpolyglutamable anti-folate, MX-68.
Topics: 2-Aminoadipic Acid; Animals; Arthritis, Experimental; Cell Division; Cells, Cultured; Collagen; Endothelium, Vascular; Fibroblasts; Folic Acid Antagonists; Humans; Leukocytes, Mononuclear; Methotrexate; Mice; Polyglutamic Acid; Tetrahydrofolate Dehydrogenase | 1996 |
Preventive effect of a novel antifolate, MX-68, in murine systemic lupus erythematosus (SLE).
Topics: 2-Aminoadipic Acid; Age Factors; Animals; Autoantibodies; Blood Urea Nitrogen; Cholesterol; Chronic Disease; Disease Models, Animal; Female; Folic Acid Antagonists; Graft vs Host Disease; Lupus Erythematosus, Systemic; Lupus Nephritis; Methotrexate; Mice; Mice, Inbred DBA; Mice, Inbred NZB; Proteinuria | 1997 |
Immunosuppressive properties of MX-68, a novel unpolyglutamatable antifolate.
Topics: 2-Aminoadipic Acid; Animals; Cells, Cultured; Female; Folic Acid Antagonists; Hypersensitivity, Delayed; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lymphocyte Activation; Lymphocytes; Methotrexate; Mice; Mice, Inbred BALB C; Spleen | 1997 |
A novel non-polyglutamable anti-folate, MX-68, inhibits the induction of experimental autoimmune uveitis in rats.
Topics: 2-Aminoadipic Acid; Animals; Arrestin; Arthritis, Experimental; Autoimmune Diseases; Cell Division; Cells, Cultured; Collagen; Concanavalin A; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Immunization; Immunosuppressive Agents; Lymphocytes; Methotrexate; Rats; Rats, Inbred Strains; Uveitis | 1998 |
Nonlinear disposition kinetics of a novel antifolate, MX-68, in rats.
Topics: 2-Aminoadipic Acid; Administration, Oral; Animals; Anion Transport Proteins; Binding Sites; Carrier Proteins; Cell Membrane; Cytosol; Dose-Response Relationship, Drug; Folic Acid Antagonists; Ion Transport; Kidney Cortex; Liver; Male; Metabolic Clearance Rate; Methotrexate; Microvilli; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1999 |
Binding and transport of methotrexate and its derivative, MX-68, across the brush-border membrane in rat kidney.
Topics: 2-Aminoadipic Acid; Animals; Biological Transport; Dose-Response Relationship, Drug; Folic Acid; Folic Acid Antagonists; Hydrogen-Ion Concentration; Kidney; Male; Methotrexate; Microvilli; Osmolar Concentration; Rats; Rats, Sprague-Dawley | 1999 |
Polyglutamation of antifolates is not required for induction of extracellular release of adenosine or expression of their anti-inflammatory effects.
Topics: 2-Aminoadipic Acid; Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cell Line; Extracellular Space; Female; Folic Acid Antagonists; Humans; Methotrexate; Mice; Mice, Inbred BALB C; Pteroylpolyglutamic Acids | 2000 |
Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Topics: 2-Aminoadipic Acid; Animals; Anion Transport Proteins; Anions; Antimetabolites; Biological Transport; Carrier Proteins; Cells, Cultured; Drug Carriers; Folic Acid; Folic Acid Antagonists; Glutathione; Hepatocytes; Hydrogen-Ion Concentration; Male; Methotrexate; Rats; Sodium; Time Factors; Transport Vesicles; Tritium | 2001 |
Polyglutamation of a novel antifolate, MX-68, is not necessary for its anti-arthritic effect.
Topics: 2-Aminoadipic Acid; Animals; Antineoplastic Agents; Antirheumatic Agents; Arthritis, Experimental; Cell Division; Cells, Cultured; Disease Models, Animal; Folic Acid Antagonists; Male; Methotrexate; Mice; Mice, Inbred DBA; Peptide Synthases; Polyglutamic Acid; Rats; Rats, Inbred Lew; Substrate Specificity; Tetrahydrofolate Dehydrogenase | 2002 |
Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68.
Topics: 2-Aminoadipic Acid; Acute Disease; Animals; Antirheumatic Agents; Arthritis; Methotrexate; Mice; Mice, Knockout; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Tumor Necrosis Factor-alpha | 2003 |
Effect of MX-68 on airway inflammation and hyperresponsiveness in mice and guinea-pigs.
Topics: 2-Aminoadipic Acid; Acetylcholine; Administration, Inhalation; Allergens; Animals; Body Weight; Bronchial Hyperreactivity; Bronchitis; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Immunoglobulins; Injections, Intraperitoneal; Interferon-gamma; Interleukin-4; Interleukin-5; Male; Methotrexate; Mice; Mice, Inbred BALB C; Ovalbumin; Prednisolone | 2004 |
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
Topics: 2-Aminoadipic Acid; Adenosine; Animals; Cardiotonic Agents; Dogs; Methotrexate; Myocardial Infarction; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theophylline | 2004 |